Severe congenital neutropenia: Inheritance and pathophysiology

Current Opinion in Hematology

Volumn 14, Issue 1, 2007, Pages 22-28

  Skokowa, Julia ^a   Germeshausen, Manuela ^a   Zeidler, Cornelia ^a   Welte, Karl ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

CN; ELA2 mutations; G CSFR mutations; LEF 1; Severe congenital neutropenia

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; LEUKOCYTE ELASTASE; LYMPHOID ENHANCER FACTOR 1; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CELL MATURATION; CONGENITAL DISORDER; DISEASE SEVERITY; DOWN REGULATION; GENE MUTATION; GENETIC HETEROGENEITY; GRANULOPOIESIS; HEMATOPOIESIS; HIGH RISK POPULATION; HUMAN; NEUTROPENIA; NEUTROPHIL COUNT; PATHOPHYSIOLOGY; PHENOTYPE; PRELEUKEMIA; PRIORITY JOURNAL; PROMYELOCYTE; REVIEW; SEVERE CONGENITAL NEUTROPENIA;

EID: 33845367673     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/00062752-200701000-00006     Document Type: Review

References (54)

1. Kostmann R. Infantile genetic agranulocytosis. Acta Pediatr Scand 1956; 45:1-78.
2. Kostmann R. Infantile genetic agranulocytosis: a review with presentation of ten new cases. Acta Pediatr Scand 1975; 64:362-368.
3. Rappeport J, Parkman R, Newburger P, et al. Correction of infantile granulocytosis (Kostmann syndrome) by allogeneic bone marrow transplantation. Am J Med 1980; 68:605-609.
4. Souza L, Boone T, Gabrilove J, et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986; 232:61-65.
5. Bonilla M, Gillio A, Ruggeiro M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989; 320:1574-1580.
6. Bonilla M, Dale D, Zeidler C, et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Hematol 1994; 88:723-730.
7. Freedman MH. Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia. Curr Opin Hematol 1997; 4:217-224.
8. Welte K, Dale D. Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol 1996; 72:158-165.
9. Welte K, Boxer L. Severe chronic neutropenia: Pathophysiology and therapy. Sem Hematol 1997; 34:267-278.
10. Welte K, Zeidler C, Dale DC. Severe congenital neutropenia. Semin Hematol 2006; 43:189-195. This is a good review on congenital neutropenia.
11. Zeidler C, Welte K, Barak Y, et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000; 95:1195-1198.
12. Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998; 91:181-186.
13. Dale D, Bonilla M, Davis M, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (Filgrastim) for treatment of severe chronic neutropenia. Blood 1993; 81:2496-2502.
14. Welte K, Zeidler C, Reiter A, et al. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 1990; 75:1056-1063.
15. Rosenberg PS, Alter BP, Bolyard AA, et al. Severe Chronic Neutropenia International Registry. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006; 107:4628-4635. The authors present excellent data on leukemogenesis in congenital neutropenia and the role of G-CSF therapy.
16. Gilman P, Jackson D, Guild H. Congenital agranulocytosis: prolonged survival and terminal acute leukemia. Blood 1971; 36:576-585.
17. Rosen R, Kang S. Congenital agranulocytosis terminating in acute myelomonocytic leukemia. J Pediatr 1979; 94:406-408.
18. Germeshausen M, Ballmaier M, Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey. Blood 2006; Sep 19 [Epub ahead of print]. The authors present excellent data on the frequency and time course of G-CSF receptor mutations in congenital neutropenia and their role in leukemogenesis.
19. Zeidler C, Boxer L, Dale DC, et al. Management of Kostmann syndrome in the G-CSF era. Br J Haematol 2000; 109:490-495.
20. Dong F, Russel KB, Tidow N, et al. Mutations in the gene for the granulocyte-colony stimulating factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 1995; 333:487-493.
21. Tidow N, Pilz C, Teichmann B, et al. Clinical relevance of point mutations in the cytoplasmatic domain of the granulocyte-colony stimulating factor gene in patients with severe congenital neutropenia. Blood 1997; 88:2369-2375.
22. Bernard T, Gale R, Evans J, et al. Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon. Br J Haematol 1998; 101:141-149.
23. Cassinat B, Bellanné-Chantelot C, Notz-Carrére A, et al. Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French neutropenia register. Leukemia 2004; 18:1553-1555.
24. Donadieu J, Leblanc T, Meunier B, et al., on behalf of the French Severe Chronic Neutropenia study group. Analysis of risk factors for myelodysplasia/leukemia and infectious death among patients with congenital neutropenia: experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005; 90:45-53.
25. Papadaki HA, Kosteas T, Gemetzi C, et al. Acute myeloid/NK precursor cell leukemia with trisomy 4 and a novel point mutation in the extracellular domain of the G-CSF receptor in a patient with chronic idiopathic neutropenia. Ann Hematol 2004; 83:345-348.
26. Tschan CA, Pilz C, Zeidler C, et al. Time course of increasing numbers of mutations in the granulocyte colony-stimulating factor receptor gene in a patient with congenital neutropenia who developed leukemia. Blood 2001; 97:1882-1884.
27. Sloand EM, Yong AS, Ramkissoon S, et al. Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Proc Natl Acad Sci U S A 2006; 103:14483-14488. This is an interesting report on G-CSF and monosomy 7.
28. Mempel K, Pietsch T, Menzel T, et al. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood 1991; 77:1919-1922.
29. Kyas U, Pietsch T, Welte K. Expression of receptors for granulocyte-colony stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia. Blood 1992; 79:1144-1147.
30. Horwitz M, Benson KF, Person RE, et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoesis. Nat Genet 1999; 23:433-436.
31. Ancliff PJ, Gale RE, Watts MJ, et al. Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood 2002; 100:707-709.
32. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000; 96:2317-2322.
33. Massullo P, Druhan LJ, Bunnell BA, et al. Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes. Blood 2005; 10:3397-3404.
34. Germeshausen M, Schulze H, Ballmaier M, et al. Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia. Br J Haematol 2001; 115:1-4.
35. Boxer LA, Stein S, Buckley D, et al. Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutations. J Pediatr 2006; 148:633-636. The authors present outstanding information on autosomal-dominant inheritance of ELA2 mutations.
36. Aprikyan AA, Kutyavin T, Stein S, et al. Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol 2003; 31:372-381.
37. Germeshausen M, Schulze H, Ballmaier M, et al. Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia. Br J Haematol 2001; 115:1-4.
38. Köllner I, Sodeik B, Schreek S, et al. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 2006; 108:493-500. Excellent report on neutrophil elastase (NE) mutations and intracellular trafficking of mutated NE protein.
39. Thusberg J, Vihinen M. Bioinformatic analysis of protein structure-function relationships: case study of leukocyte elastase (ELA2) missense mutations. Hum Mutat 2006; Sep 19 [Epub ahead of print]. This is an interesting bioinformatic analysis of ELA2 mutations.
40. Li FQ, Horwitz M. Characterization of mutant neutrophil elastase in severe congenital neutropenia. J Biol Chem 2001; 276:14230-14241.
41. Benson KF, Li FQ, Person RE, et al. Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat Genet 2003; 35:90-96.
42. Kawaguchi H, Kobayashi M, Nakamura K, et al. Dysregulation of transcriptions in primary granule constituents during myeloid proliferation and differentiation in patients with severe congenital neutropenia. J Leukoc Biol 2003; 73:225-234.
43. Sera Y, Kawaguchi H, Nakamura K, et al. A comparison of the defective granulopoiesis in childhood cyclic neutropenia and in severe congenital neutropenia. Haematologica 2005; 90:1032-1041.
44. Lausen J, Liu S, Fliegauf M, et al. ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO. Oncogene 2006; 25:1349-1357. The authors provide excellent information on ELA2 regulation on the transcriptional level.
45. Skokowa J, Cario G, Uenalan M, et al. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med 2006; 12:1191-1197. This describes outstanding new findings in the pathophysiology of congenital neutropenia, demonstrating a common mechanism of maturation arrest of myeloid progenitors.
46. Li FQ, Person RE, Takemaru K, et al. Lymphoid enhancer factor-1 links two hereditary leukemia syndromes through core-binding factor alpha regulation of ELA2. J Biol Chem 2004; 279:2873-2884.
47. Bellanne-Chantelot C, Clauin S, Leblanc T, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood 2004; 103:4119-4125.
48. Cario G, Skokowa J, Wang Z, et al. Heterogeneous expression pattern of proand antiapoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor. Br J Haematol 2005; 129:275-278.
49. Germeshausen M, Schulze H, Kratz C, et al. An acquired G-CSF receptor mutation results in increased proliferation of CMML cells from a patient with severe congenital neutropenia. Leukemia 2005; 19:611-617.
50. Hermans MH, van de Geijn GJ, Antonissen C, et al. Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood 2003; 101:2584-2590.
51. Jeha S, Chan KW, Aprikyan AG, et al. Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia. Blood 2000; 96:3647-3649.
52. van de Geijn GJ, Gits J, Aarts LH, et al. G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact. Blood 2004; 104:667-674.
53. Mermel CH, McLemore ML, Liu F, et al. Src-family kinases are important negative regulators of G-CSF dependent granulopoiesis. Blood 2006; 108:2562-2568.
54. Germeshausen M, Ballmaier M, Schulze H, et al. Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood 2001; 97:829-830.